Author:
Feenstra Anita,Kirch Darrell G.,Coggiano Mark A.,Wyatt Richard Jed
Reference60 articles.
1. Baker, H. E, Ridley, R. M., Crow, T. J., Bloxham, C. A., Parry, R. P., and Tyrrell, D. A. J., 1983, An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease, Psychol. Med. 13: 499–511.
2. Bednarik D. P., Mosca, J. D., and Raj, N. B. K., 1987, Methylation as a modulator of expression of human immunodeficiency virus, J. Virol. 61: 1253–1257.
3. Burns, J. C., Geha, R. S., Schneeberger, E. E., Newburger, J. W., Rosen, E. S., Glezen, L. S., Natale, J., and Huang, A. S., 1986, Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease, Nature 323: 814–816.
4. Coffey, C. E., Sullivan, J. L., and Rice, J. R., 1983, T lymphocytes in schizophrenia, Biol. Psychiatry 18: 113–119.
5. Cook, S. D., and Dowling, P C., 1980, Multiple sclerosis and viruses: An overview, Neurology 30:113–119. Crow, T. J., 1983, Is schizophrenia an infectious disease? Lancet 1: 173–175.